Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer

Oncology

Volumn 79, Issue 3-4, 2011, Pages 238-246

  Ishikawa, Masako ^a   Nakayama, Kentaro ^a   Rahman, Mohammed Tanjimur ^a   Rahman, Munmun ^a   Katagiri, Atsuko ^a   Iida, Kouji ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Endometrial cancer; MKK4; Tumor suppresser gene

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER PATIENT; CANCER SURVIVAL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MOUSE; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; TUMOR XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CARCINOMA, ENDOMETRIOID; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MAP KINASE KINASE 4; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952106612     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322644     Document Type: Article

References (20)

1. Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72-81.
2. Shiozawa T, Konishi I: Early endometrial carcinoma: clinicopathology, hormonal as-pects, molecular genetics, diagnosis, and treatment. Int J Clin Oncol 2006; 11:13-21. (Pubitemid 43320322)
3. Matias-Guiu X, Catasus L, Bussaglia E, La-garda H, Garcia A, Pons C, Munoz J, Ar-guelles R, Machin P, Prat J: Molecular pa-thology of endometrial hyperplasia and car-cinoma. Hum Pathol 2001; 32: 569-577. (Pubitemid 32601237)
4. Lax SF: Molecular genetic pathways in vari-ous types of endometrial carcinoma: from a phenotypical to a molecular-based classifi-cation. Virchows Arch 2004; 444: 213-223. (Pubitemid 38446432)
5. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH: Mu-tations in PTEN are frequent in endometrial carcinoma but rare in other common gyne-cological malignancies. Cancer Res 1997; 57: 3935-3940. (Pubitemid 27427679)
6. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L: p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997; 150:177-185. (Pubitemid 27027108)
7. Su GH, Hilgers W, Shekher MC, Tang DJ, Yeo CJ, Hruban RH, Kern SE: Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tu-mor suppressor gene. Cancer Res 1998; 58: 2339-2342. (Pubitemid 28252690)
8. Nakayama K, Nakayama N, Davidson B, Katabuchi H, Kurman RJ, Velculescu VE, Shih IeM, Wang TL: Homozygous deletion of MKK4 in ovarian serous carcinoma. Cancer Biol Ther 2006; 5:630-634. (Pubitemid 44024717)
9. Teng DH, Perry WL 3rd, Hogan JK, Baumgard M, Bell R, Berry S, Davis T, Frank D, Frye C, Hattier T, Hu R, Jammulapati S, Janecki T, Leavitt A, Mitchell JT, Pero R, Sexton D, Schroeder M, Su PH, Swedlund B, Kyriakis JM, Avruch J, Bartel P, Wong AK, Tavtigian SV, et al: Human mitogen-activat-ed protein kinase kinase 4 as a candidate tu-mor suppressor. Cancer Res 1997; 57: 4177-4182. (Pubitemid 27413418)
10. Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Miyazaki K: Loss of MKK4 ex-pression in ovarian cancer: a potential role for the epithelial to mesenchymal transition. Int J Cancer 2011; 128:94-104.
11. Nakayama K, Miyazaki K, Kanzaki A, Fukumoto M, Takebayashi Y: Expression and cis-platin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines. Oncol Rep 2001; 8:1285-1287. (Pubitemid 33758731)
12. United Kingdom Co-Ordinating Commit-tee on Cancer Research (UKCCCR) Guide-lines for the Welfare of Animals in Experi-mental Neoplasia (Second Edition). Br J Cancer 1998; 77:1-10.
13. Kim HL, Vander Griend DJ, Yang X, Benson DA, Dubauskas Z, Yoshida BA, Chekmareva MA, Ichikawa Y, Sokoloff MH, Zhan P, Karrison T, Lin A, Stadler WM, Ichikawa T, Rubin MA, Rinker-Schaeffer CW: Mitogen-ac-tivated protein kinase kinase 4 metastasis suppressor gene expression is inversely re-lated to histological pattern in advancing hu-man prostatic cancers. Cancer Res 2001; 61: 2833-2837. (Pubitemid 32691920)
14. Xin W, Yun KJ, Ricci F, Zahurak M, Qiu W, Su GH, Yeo CJ, Hruban RH, Kern SE, Iacobuzio-Donahue CA: MAP2K4/MKK4 ex-pression in pancreatic cancer: genetic valida-tion of immunohistochemistry and relation-ship to disease course. Clin Cancer Res 2004; 10: 8516-8520. (Pubitemid 40053418)
15. Wu CW, Li AF, Chi CW, Huang CL, Shen KH, Liu WY, Lin W: Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Am J Pathol 2000; 156:2007-2015. (Pubitemid 30641769)
16. Huang C, Huang K, Wang C, Jiang ZD, Li XX, Wang HP, Chen HY: Overexpression of mito-gen-activated protein kinase kinase 4 and nu-clear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Oncol Rep 2009; 22:89-95.
17. Reno EM, Haughian JM, Jackson TA, Thorne AM, Bradford AP: c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells. Apoptosis 2009; 14: 809-820.
18. Yoshida BA, Dubauskas Z, Chekmareva MA, Christiano TR Stadler WM, Rinker-Schaef-fer CW: Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metasta-sis suppressor gene encoded by human chro-mosome 17. Cancer Res 1999; 59: 5483-5487. (Pubitemid 29526462)
19. Yamada SD, Hickson JA, Hrobowski Y Vander Griend DJ, Benson D, Montag A, Karrison T, Huo D, Rutgers J, Adams S, Rinker-Schaeffer CW: Mitogen-activated protein kinase kinase 4 (MKK4) acts as a me-tastasis suppressor gene in human ovarian carcinoma. Cancer Res 2002; 62: 6717-6723. (Pubitemid 35364143)
20. Hickson JA, Huo D, Vander Griend DJ, Lin A, Rinker-Schaeffer CW, Yamada SD: The p38 kinases MKK4 and MKK6 suppress met-astatic colonization in human ovarian carci-noma. Cancer Res 2006; 66:2264-2270.